Kilitch Drugs (India) Balance Sheet Health
Financial Health criteria checks 5/6
Kilitch Drugs (India) has a total shareholder equity of ₹1.9B and total debt of ₹324.1M, which brings its debt-to-equity ratio to 17.2%. Its total assets and total liabilities are ₹2.6B and ₹709.5M respectively. Kilitch Drugs (India)'s EBIT is ₹154.0M making its interest coverage ratio 3.4. It has cash and short-term investments of ₹588.5M.
Key information
17.2%
Debt to equity ratio
₹324.12m
Debt
| Interest coverage ratio | 3.4x |
| Cash | ₹588.52m |
| Equity | ₹1.88b |
| Total liabilities | ₹709.50m |
| Total assets | ₹2.59b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524500's short term assets (₹1.5B) exceed its short term liabilities (₹707.8M).
Long Term Liabilities: 524500's short term assets (₹1.5B) exceed its long term liabilities (₹1.7M).
Debt to Equity History and Analysis
Debt Level: 524500 has more cash than its total debt.
Reducing Debt: 524500's debt to equity ratio has increased from 10.9% to 17.2% over the past 5 years.
Debt Coverage: 524500's debt is well covered by operating cash flow (64.9%).
Interest Coverage: 524500's interest payments on its debt are well covered by EBIT (3.4x coverage).